Montes Archimedes Acquisition (ROIV)
(Delayed Data from NSDQ)
$10.90 USD
-0.04 (-0.37%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $10.90 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
06/26/2024
Time: -- |
3/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Montes Archimedes Acquisition (ROIV) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.27 per share. This reflects a positive earnings surprise of 22.22%. Look out for ROIV's next earnings release expected on June 26, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year decrease of 25%.
Earnings History
Price & Consensus
Zacks News for ROIV
Immunovant (IMVT) Soars on Upbeat Initial IMVT-1402 Study Data
ROIV: What are Zacks experts saying now?
Zacks Private Portfolio Services